Possibilities of modern hormone replacement therapy for the correction of urogenital estrogen deficiency syndrome in women with the pathological course of menopause

M. A. Zvychayny; Звычайный М. А.; V. I. Konovalov; Коновалов В. И.; A. V. Vorontsova; Воронцова А. В.; A. V. Gorlenko; Горленко А. В.; S. Yu. Pristolenko; Пристоленко С. Ю.; L. N. Pristolenko; Пристоленко Л. Н.

doi:10.17816/JOWD100361

Possibilities of modern hormone replacement therapy for the correction of urogenital estrogen deficiency syndrome in women with the pathological course of menopause

Authors: Zvychayny M.A.¹, Konovalov V.I.¹, Vorontsova A.V.¹, Gorlenko A.V.¹, Pristolenko S.Y.¹, Pristolenko L.N.¹
Affiliations:
1. Ural State Medical Academy
Issue: Vol 49, No 5S (2000)
Pages: 45-45
Section: Articles
URL: https://journals.rcsi.science/jowd/article/view/100361
DOI: https://doi.org/10.17816/JOWD100361
ID: 100361

Cite item

Full Text

Abstract
Full Text
About the authors
References
Supplementary files
Statistics

Abstract

To find out the potential of modern hormone replacement therapy (HRT) drugs to relieve urogenital disturbances (UGR) in women with menopausal pathology, we examined 65 premenopausal patients (including 23 women with a history of hysterectomy) with various degrees of UGR and who used HRT according to the conventional regimens: 23 patients on Climen, 19 on Climonorm, and 23 on Climara. None of the women had received hormonal treatment for at least 6 months prior to the study.